Core Laboratories N.V.CLBNYSE
Loading
Year-over-year net income growth rate
Percentile
P23
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -50.26% |
| Q3 2025 | 33.88% |
| Q2 2025 | 7006.49% |
| Q1 2025 | -102.08% |
| Q4 2024 | -36.97% |
| Q3 2024 | 30.04% |
| Q2 2024 | 180.50% |
| Q1 2024 | 46.43% |
| Q4 2023 | -76.25% |
| Q3 2023 | -59.48% |
| Q2 2023 | 862.75% |
| Q1 2023 | -64.85% |
| Q4 2022 | -10.27% |
| Q3 2022 | 6.48% |
| Q2 2022 | 474.26% |
| Q1 2022 | -170.24% |
| Q4 2021 | 207.55% |
| Q3 2021 | -89.16% |
| Q2 2021 | -0.56% |
| Q1 2021 | -40.13% |
| Q4 2020 | 356.87% |
| Q3 2020 | 151.84% |
| Q2 2020 | 94.73% |
| Q1 2020 | -1149.57% |
| Q4 2019 | -56.47% |
| Q3 2019 | -13.44% |
| Q2 2019 | -32.33% |
| Q1 2019 | 358.52% |
| Q4 2018 | -60.58% |
| Q3 2018 | -9.45% |
| Q2 2018 | 5.21% |
| Q1 2018 | 8.46% |
| Q4 2017 | 2.87% |
| Q3 2017 | -7.07% |
| Q2 2017 | 28.50% |
| Q1 2017 | 14.22% |
| Q4 2016 | -7.60% |
| Q3 2016 | 0.64% |
| Q2 2016 | 10.22% |
| Q1 2016 | -2.18% |